• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Current levels of conflict of interest disclosure in medical publications from Korea.韩国医学出版物中当前的利益冲突披露水平。
J Korean Med Sci. 2013 Jul;28(7):978-82. doi: 10.3346/jkms.2013.28.7.978. Epub 2013 Jul 3.
2
Conflict of interest reporting in biomedical journals published in China.中国生物医学期刊中的利益冲突报告。
Account Res. 2017;24(8):451-457. doi: 10.1080/08989621.2017.1392246. Epub 2017 Oct 30.
3
Nursing Journal Policies on Disclosure and Management of Conflicts of Interest.护理期刊利益冲突披露和管理政策。
J Nurs Scholarsh. 2020 Nov;52(6):680-687. doi: 10.1111/jnu.12605. Epub 2020 Oct 19.
4
Conflict of interest policies in science and medical journals: editorial practices and author disclosures.科学与医学期刊中的利益冲突政策:编辑实践与作者披露
Sci Eng Ethics. 2001 Apr;7(2):205-18. doi: 10.1007/s11948-001-0041-7.
5
Requirements and definitions in conflict of interest policies of medical journals.医学期刊利益冲突政策中的要求和定义。
JAMA. 2009 Nov 25;302(20):2230-4. doi: 10.1001/jama.2009.1669.
6
An analysis of toxicology and medical journal conflict-of-interest polices.毒理学和医学期刊利益冲突政策分析。
Account Res. 2009;16(5):235-53. doi: 10.1080/08989620903190273.
7
Conflicts of interest disclosure policies among Chinese medical journals: A cross-sectional study.中文医学期刊利益冲突披露政策:一项横断面研究。
PLoS One. 2019 Jul 9;14(7):e0219564. doi: 10.1371/journal.pone.0219564. eCollection 2019.
8
Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.同行评审生物医学期刊中的利益冲突披露政策与实践
J Gen Intern Med. 2006 Dec;21(12):1248-52. doi: 10.1111/j.1525-1497.2006.00598.x.
9
Conflict-of-interest disclosure at medical journals in Japan: a nationwide survey of the practices of journal secretariats.日本医学期刊的利益冲突披露:对期刊秘书处做法的全国性调查。
BMJ Open. 2015 Aug 26;5(8):e007957. doi: 10.1136/bmjopen-2015-007957.
10
Financial, nonfinancial and editors' conflicts of interest in high-impact biomedical journals.高影响力生物医学期刊中的财务、非财务和编辑利益冲突。
Eur J Clin Invest. 2013 Jul;43(7):660-7. doi: 10.1111/eci.12090. Epub 2013 Apr 1.

引用本文的文献

1
A literature review of non-financial conflicts of interest in healthcare research and publication.医疗保健研究与出版中利益冲突的文献综述。 (原文表述似乎有误,推测正确内容为“A literature review of non - financial conflicts of interest in healthcare research and publication”,翻译为“医疗保健研究与出版中非财务利益冲突的文献综述” ) 按照正确内容翻译为:医疗保健研究与出版中非财务利益冲突的文献综述。
BMC Med Ethics. 2025 May 15;26(1):61. doi: 10.1186/s12910-025-01221-5.
2
A guide to applying the Good Publication Practice 3 guidelines in the Asia-Pacific region.在亚太地区应用《良好出版规范3指南》的指南。
Res Integr Peer Rev. 2019 Oct 2;4:21. doi: 10.1186/s41073-019-0079-1. eCollection 2019.
3
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors.生物医学出版物中的利益冲突:作者、同行评审人员及编辑应考虑的事项
Croat Med J. 2013 Dec;54(6):600-8. doi: 10.3325/cmj.2013.54.600.

本文引用的文献

1
Is conflict of interest in our best interest?利益冲突符合我们的最大利益吗?
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1063-8. doi: 10.1007/s00259-010-1429-x.
2
Requirements and definitions in conflict of interest policies of medical journals.医学期刊利益冲突政策中的要求和定义。
JAMA. 2009 Nov 25;302(20):2230-4. doi: 10.1001/jama.2009.1669.
3
Pharmaceutical company funding and its consequences: a qualitative systematic review.制药公司的资金投入及其影响:一项定性系统综述
Contemp Clin Trials. 2008 Mar;29(2):109-13. doi: 10.1016/j.cct.2007.08.001. Epub 2007 Aug 16.
4
Disclosing conflicts of interest in German publications concerning health services research.在德国关于卫生服务研究的出版物中披露利益冲突。
BMC Health Serv Res. 2007 Jun 1;7:78. doi: 10.1186/1472-6963-7-78.
5
Update on JAMA's conflict of interest policy.《美国医学会杂志》利益冲突政策更新
JAMA. 2006 Jul 12;296(2):220-1. doi: 10.1001/jama.296.2.220.
6
Bias in published cost effectiveness studies: systematic review.已发表的成本效益研究中的偏倚:系统评价
BMJ. 2006 Mar 25;332(7543):699-703. doi: 10.1136/bmj.38737.607558.80. Epub 2006 Feb 22.
7
A statement by the editors of The Lancet.《柳叶刀》编辑的一份声明。
Lancet. 2004 Mar 6;363(9411):820-1. doi: 10.1016/S0140-6736(04)15699-7.
8
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.医学和外科随机试验中行业资助与具有统计学意义的支持行业的研究结果之间的关联。
CMAJ. 2004 Feb 17;170(4):477-80.
9
Pharmaceutical industry sponsorship and research outcome and quality: systematic review.制药行业赞助与研究结果及质量:系统评价
BMJ. 2003 May 31;326(7400):1167-70. doi: 10.1136/bmj.326.7400.1167.
10
Scope and impact of financial conflicts of interest in biomedical research: a systematic review.生物医学研究中经济利益冲突的范围与影响:一项系统综述
JAMA. 2003;289(4):454-65. doi: 10.1001/jama.289.4.454.

韩国医学出版物中当前的利益冲突披露水平。

Current levels of conflict of interest disclosure in medical publications from Korea.

机构信息

Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2013 Jul;28(7):978-82. doi: 10.3346/jkms.2013.28.7.978. Epub 2013 Jul 3.

DOI:10.3346/jkms.2013.28.7.978
PMID:23853478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3708095/
Abstract

Medical research should be fully transparent. The aims of this study were to determine the prevalence of author-related conflict of interest (COI) policies and evaluate the actual state of COI disclosure in Korean medical journals. To determine the prevalence of author-related COI policies, we examined the 198 medical journals listed in the KoreaMed database. To investigate the actual state of COI disclosures in published papers, we analyzed the publications in a representative medical journal, the Journal of the Korean Medical Science, from the perspective of the relevance of the ethics of COI disclosure. A total of 164 (82.8%) journals required an author's statement of COI as a criterion for publication. Of these 164, most of them focused on financial COI, with 101 (61.6%) presenting the information related to COI disclosures as a separate paragraph with a clear title. We identified 114 articles published by the Journal of the Korean Medical Science over a seven-year period, from January, 2006 to December, 2012. Of these, 65 papers (57%) included an author's statement of COI. We found that the policies of Korean medical journals regarding the disclosure of author COIs are still behind the internationally suggested level.

摘要

医学研究应该完全透明。本研究的目的是确定韩国医学期刊中作者相关利益冲突(COI)政策的流行情况,并评估 COI 披露的实际状况。为了确定作者相关 COI 政策的流行情况,我们检查了 KoreaMed 数据库中列出的 198 种医学期刊。为了从 COI 披露伦理的相关性角度调查已发表论文中 COI 披露的实际情况,我们分析了代表性医学期刊《韩国医学科学杂志》的出版物。共有 164 种(82.8%)期刊将作者的 COI 声明作为发表标准。在这 164 种期刊中,大多数都关注财务 COI,其中 101 种(61.6%)将与 COI 披露相关的信息作为单独的段落,并附有明确的标题。我们确定了《韩国医学科学杂志》在 2006 年 1 月至 2012 年 12 月的七年期间发表的 114 篇文章。其中,65 篇论文(57%)包含作者的 COI 声明。我们发现,韩国医学期刊关于披露作者 COI 的政策仍落后于国际建议水平。